Annual Total Liabilities
$12.01 M
-$508.60 K-4.06%
December 31, 2023
Summary
- As of February 8, 2025, IMRX annual total liabilities is $12.01 million, with the most recent change of -$508.60 thousand (-4.06%) on December 31, 2023.
- During the last 3 years, IMRX annual total liabilities has fallen by -$48.90 million (-80.28%).
- IMRX annual total liabilities is now -80.28% below its all-time high of $60.90 million, reached on December 31, 2020.
Performance
IMRX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$10.84 M
+$54.70 K+0.51%
September 30, 2024
Summary
- As of February 8, 2025, IMRX quarterly total liabilities is $10.84 million, with the most recent change of +$54.70 thousand (+0.51%) on September 30, 2024.
- Over the past year, IMRX quarterly total liabilities has increased by +$1.58 million (+17.02%).
- IMRX quarterly total liabilities is now -87.72% below its all-time high of $88.23 million, reached on June 30, 2021.
Performance
IMRX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
IMRX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.1% | +17.0% |
| 3 y3 years | -80.3% | -13.4% |
| 5 y5 years | -41.8% | -13.4% |
IMRX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.1% | +12.0% | -13.4% | +29.1% |
| 5 y | 5-year | -80.3% | +12.0% | -87.7% | +230.2% |
| alltime | all time | -80.3% | +12.0% | -87.7% | +230.2% |
Immuneering Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $10.84 M(+0.5%) |
| Jun 2024 | - | $10.78 M(+16.4%) |
| Mar 2024 | - | $9.26 M(-22.9%) |
| Dec 2023 | $12.01 M(-4.1%) | $12.01 M(+21.7%) |
| Sep 2023 | - | $9.86 M(+0.7%) |
| Jun 2023 | - | $9.79 M(-1.2%) |
| Mar 2023 | - | $9.91 M(-20.9%) |
| Dec 2022 | $12.52 M | $12.52 M(+6.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $11.80 M(+39.5%) |
| Jun 2022 | - | $8.46 M(+0.8%) |
| Mar 2022 | - | $8.39 M(-21.8%) |
| Dec 2021 | $10.72 M(-82.4%) | $10.72 M(+86.6%) |
| Sep 2021 | - | $5.75 M(-93.5%) |
| Jun 2021 | - | $88.23 M(+2588.1%) |
| Mar 2021 | - | $3.28 M(-94.6%) |
| Dec 2020 | $60.90 M(+195.3%) | $60.90 M |
| Dec 2019 | $20.63 M | - |
FAQ
- What is Immuneering annual total liabilities?
- What is the all time high annual total liabilities for Immuneering?
- What is Immuneering annual total liabilities year-on-year change?
- What is Immuneering quarterly total liabilities?
- What is the all time high quarterly total liabilities for Immuneering?
- What is Immuneering quarterly total liabilities year-on-year change?
What is Immuneering annual total liabilities?
The current annual total liabilities of IMRX is $12.01 M
What is the all time high annual total liabilities for Immuneering?
Immuneering all-time high annual total liabilities is $60.90 M
What is Immuneering annual total liabilities year-on-year change?
Over the past year, IMRX annual total liabilities has changed by -$508.60 K (-4.06%)
What is Immuneering quarterly total liabilities?
The current quarterly total liabilities of IMRX is $10.84 M
What is the all time high quarterly total liabilities for Immuneering?
Immuneering all-time high quarterly total liabilities is $88.23 M
What is Immuneering quarterly total liabilities year-on-year change?
Over the past year, IMRX quarterly total liabilities has changed by +$1.58 M (+17.02%)